News Formal

Galway-based Channelle Pharma to be sold for €300m

  • 📰 IrishTimesBiz
  • ⏱ Reading Time:
  • 5 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 77%

Business News

Channelle Pharma,Sale,UK Private Equity Firm

Galway-based generic drugmaker Channelle Pharma is on track to be sold to UK private equity firm Exponent in a deal said to be worth about €300 million. The company has veterinary and human drug licenses in the EU. Other private equity firms were also interested in the bidding process. Channelle Pharma is estimated to make a profit of about €25 million a year.

Galway-based generic drugmaker Channelle Pharma is set to be sold to UK private equity firm Exponent for about €300 million. The company has veterinary and human drug licenses in the EU. Other private equity firms were also interested in the bidding process.

Channelle Pharma is estimated to make a profit of about €25 million a year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines